TXN vs. LRCX: Which Semiconductor Stock Is the Better Buy Right Now?
π Texas Instruments Q1 2026 revenues increased 19% year-over-year to $4.83 billion with EPS rising 31% to $1.68.
π TXN data center business annual run rate reached ~$1.2 billion in 2025, growing over 50% year-over-year.
βοΈ Lam Research raised its 2026 wafer fabrication equipment spending outlook to $140 billion from $135 billion.
π LRCX Q3 fiscal 2026 revenues rose 23.8% to $5.84 billion, beating consensus estimates by 1.3%.
π° TXN non-GAAP gross margin expanded 120 bps to 58% in Q1 2026 driven by manufacturing scale.
π¬ LRCX advanced packaging revenues expected to grow more than 50% in calendar year 2026.
π΅ TXN trades at a forward P/E of 36.94, significantly lower than LRCX's 48.82 multiple.
π LRCX shares gained 121.3% year-to-date compared to TXN's 74.4% increase in the same period.
π TXN holds a Zacks Rank #1 (Strong Buy) while LRCX carries a Zacks Rank #2 (Buy).
π TXN supplies essential analog chips for power delivery, cooling, and connectivity in data centers.
- TXN delivered strong Q1 2026 results with 19% revenue growth and 31% EPS growth, demonstrating robust execution.
- The company's data center segment is a major growth engine, with Q1 2026 revenues surging 90% year-over-year.
- TXN's manufacturing strategy is yielding results, expanding non-GAAP gross margins by 120 basis points to 58%.
- Lam Research raised its full-year 2026 equipment spending outlook to $140 billion, indicating strong customer demand.
- LRCX beat earnings estimates in Q3 fiscal 2026 with EPS surpassing consensus by 8.1%.
- Advanced packaging revenues for LRCX are projected to grow over 50% in calendar 2026 due to AI chip demand.
- TXN offers a more attractive valuation with a forward P/E of 36.94 compared to LRCX's 48.82.
- Both companies benefit from the broader AI-driven technology cycle and recovery in semiconductor demand.
- Lam Research trades at a premium valuation with a forward P/E of 48.82, which may limit upside if growth slows.
- TXN's Q2 2026 revenue guidance ($5.00-$5.40 billion) is slightly below the Zacks Consensus Estimate of $5.22 billion.
- LRCX's stock has already rallied significantly with a 121.3% year-to-date gain, potentially pricing in much of the AI optimism.